FDA NDC Directory · JSON-LD · Markdown

LIBTAYO

NDC 61755-008 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namecemiplimab-rwlc
Labeler / ManufacturerRegeneron Pharmaceuticals, Inc.
Marketing categoryBiologic License Application · App BLA761097
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsCEMIPLIMAB (50 mg/mL)
Marketing started20180928
Package count1

External sources

Source: openFDA. Public-domain (CC0).